1[1]Polyak K, Kato JY, Solomon MJ, et al. p27kipl, a cyclin-CDK inhibitor, links transforming growth factor βand contact inhibition to cell cycle arrest[J].Genes Dev, 1994,8(1) :9-22.
2[2]Fero ML, Rivkin M, Tasch M, et al. A syndrome of multiorgan hyperplasia with features of gigantism,tumorigenesis, and female sterility in p27(kip1)- deficient mice[J]. Cell, 1996, 85(5):733-744.
3[3]Tokumoto YM, Apperly JA, Gao FB, et al. Posttranscriptional regulation of p18 and p27 Cdk inhibitor proteins and the timing of oligodendrocyte differentiation[J]. Dev Biol, 2002, 245(1) :224-234.
5[5]St Croix B, Florenes VA, Rak JW, et al. Impact of the cyclin-dependent kinase inhibitor p27Kipl on resistance of tumor cells to anticancer agents[J]. Nat Med, 1996, 2(11):1 204-1 210.
6[6]Singh SP, Lipman J, Goldman H, et al. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma[J]. Cancer Res, 1998, 58(8):1730- 1 735.
7[7]Shibata H, Matsubara O, Wakiyama H, et al. The role of cyclin- dependent kinase inhibitor p27 in squamous cell carcinoma of the esophagus[J]. Pathol Res Pract, 2001, 197(3) :157-164.
8[8]So JB, Samarasinge K, Raju GC, et al. Expression of cell-cycle regulators p27 and cyclin E correlates with survival in gastric carcinoma patients[J]. J Surg Res,2000,94(1) :56-60.
9[9]Kim DH, Lee HI, Nam ES, et al. Reduced expression of the cell-cycle inhibitor p27Kipl is associated with progression and lymph node metastasis of gastric carcinoma[J ]. Histopathology, 2000, 36 (3): 245-251.
10[10]Kim SG, Kim SN, Jong HS, etal. Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-betal- induced apoptosis in human gastric cancer cells [J]. Oncogene, 2001, 20(10):1 254-1 265.
